Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Avenue Therapeutics
(ATXI) Q3 2024
Earnings
ATXI
Aug 9
Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-15.4
-10.08
-4.76
0.56
Details
Expected EPS
-1.05
Actual EPS
-6.43
Surprise EPS
-5.38
Surprise Percent
-512.38%
Description
Avenue Therapeutics (ATXI) has reported earnings of -6.43 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login